Skip to main content
. 2017 Dec;8(6):985–989. doi: 10.21037/jgo.2017.08.16

Figure 1.

Figure 1

Study participant serum concentrations for CRP and IL-6. Normalized serum concentrations of (A) CRP and (B) IL-6 at baseline and after one cycle of treatment with pacritinib. Each line represents an individual patient who had both the blood test at baseline and at the beginning of cycle 2. CRP, C-reactive protein.